Operating Lease, Right-of-Use Asset of CRESCENT BIOPHARMA, INC. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CRESCENT BIOPHARMA, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • CRESCENT BIOPHARMA, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,564,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,564,000 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,607,000 +$1,182,791 +279% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q4 2024 $0 -$767,828 -100% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $424,209 -$758,291 -64% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $598,257 +$66,201 +12% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $767,828 +$16,654 +2.2% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $955,310 -$9,712 -1% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $1,182,500 +$8,794 +0.75% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $532,056 -$845,315 -61% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $751,174 -$825,011 -52% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $965,022 -$805,241 -45% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,173,706 -$785,997 -40% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $1,377,371 -$767,267 -36% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 $1,576,185 -$749,039 -32% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $1,770,263 -$731,302 -29% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $1,959,703 -$713,953 -27% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $2,144,638 -$697,169 -25% 31 Mar 2021 10-Q 03 May 2021 2021 Q1
Q4 2020 $2,325,224 -$680,845 -23% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 $2,501,565 -$664,974 -21% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $2,673,656 -$649,638 -20% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $2,841,807 -$634,645 -18% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $3,006,069 -$593,931 -16% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $3,166,539 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $3,323,294 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $3,476,452 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $3,600,000 01 Jan 2019 10-K 28 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.